Loss of expression of core Hippo pathway components and overexpression or nuclear accumulation of YAP and TAZ are evident in various RCC subtypes which correlate with tumor grade and poor patient survival [15,17,23,27]. The gene discussed is YAP1; the disease is renal cell carcinoma.